Showing results (101-110 of 141) with videos related to

Sort By:
Pageof 15
BMC Infectious Diseases|August 8, 2022
Comparison of amphotericin B deoxycholate in combination with either flucytosine or fluconazole, and voriconazole plus flucytosine for the treatment of HIV-associated cryptococcal meningitis: a prospective multicenter study in ChinaTing Zhao, Xiaolei Xu, Yushan Wu, et al.
Virology|December 4, 2020
Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infectionRentao Yu, Shun Tan, Yunjie Dan, et al.
BMC Infectious Diseases|October 20, 2023
Severe anemia, severe leukopenia, and severe thrombocytopenia of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated talaromycosis: a subgroup analysis of a prospective multicenter cohort studyYihong Zhou, Tao Lu, Yan Li, et al.
AIDS Research and Human Retroviruses|June 17, 2020
HIV Infection Does Not Increase 10-Week Mortality of Chinese Cryptococcal Meningitis PatientsLijun Xu, Jianhua Yu, Bin Zheng, et al.
Open Medicine (Warsaw, Poland)|December 18, 2020
Predictive factors of progression to severe COVID-19Yi-Hong Zhou, Huan Li, Yuan-Yuan Qin, et al.
Frontiers in Immunology|July 18, 2018
Evaluation of Blood-Based Antibody Rapid Testing for HIV Early Therapy: A Meta-Analysis of the EvidenceXiaojie Huang, Xinchao Liu, Jieqing Chen, et al.
Stem Cell Research & Therapy|November 20, 2023
The influence of inflammation on the characteristics of adipose-derived mesenchymal stem cells (ADMSCs) and tissue repair capability in a hepatic injury mouse modelJingfang Xiao, Xiaoyuan Gong, Zhenlan Fu, et al.
Frontiers in Medicine|May 16, 2022
Medication Non-adherence and Condomless Anal Intercourse Increased Substantially During the COVID-19 Pandemic Among MSM PrEP Users: A Retrospective Cohort Study in Four Chinese MetropolisesYangyang Gao, Qinghai Hu, Sequoia I Leuba, et al.
Journal of the International AIDS Society|October 29, 2025
Cognitive and mental health significantly contribute to disability in people ageing with HIV in Asia: an observational case-control studyGrace Lui, Yaokai Chen, Chien-Ching Hung, et al.
The Lancet Regional Health. Western Pacific|August 2, 2024
Switch to fixed-dose ainuovirine, lamivudine, and tenofovir DF <i>versus</i> elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trialFujie Zhang, Hao Wu, Weiping Cai, et al.
Pageof 15